Can people with resistant HIV omit NRTIs when switching from a failing regimen?
New pro-drug tenofovir alafenamide appears equally effective but better tolerated
Slow progress in expansion of voluntary circumcision coverage
Dosing of key TB drug rifampicin could go higher
Once-weekly continuation phase TB treatment equals standard of care
Dually active antiretroviral therapy protects against hepatitis B infection
UK healthcare workers need better information and guidance on HIV criminalisation
Continuing cotrimoxazole in children on ART reduces the risk of hospitalisation
Black gay men run higher risk of HIV infection despite fewer partners
